Upgrade to SI Premium - Free Trial

Form 3 Alibaba Group Holding For: Mar 18 Filed by: Wu Yongming

March 18, 2026 8:11 AM
FORM 3 UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

INITIAL STATEMENT OF BENEFICIAL OWNERSHIP OF SECURITIES

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940
OMB APPROVAL
OMB Number: 3235-0104
Expires: December 31, 2014
Estimated average burden
hours per response: 0.5
1. Name and Address of Reporting Person *
Wu Yongming
(Last) (First) (Middle)
26/F TOWER ONE, TIMES SQUARE
1 MATHESON STREET, CAUSEWAY BAY
(Street)
HONG KONG 00000
(City) (State) (Zip)
2. Date of Event Requiring Statement (Month/Day/Year)
03/18/2026 		3. Issuer Name and Ticker or Trading Symbol
Alibaba Group Holding Ltd [ BABA ]
4. Relationship of Reporting Person(s) to Issuer
(Check all applicable)
X Director 10% Owner
X Officer (give title below) Other (specify below)
Chief Executive Officer
 5. If Amendment, Date of Original Filed (Month/Day/Year)
6. Individual or Joint/Group Filing (Check Applicable Line)
X Form filed by One Reporting Person
Form filed by More than One Reporting Person
Table I - Non-Derivative Securities Beneficially Owned
1. Title of Security (Instr. 4) 2. Amount of Securities Beneficially Owned (Instr. 4) 3. Ownership Form: Direct (D) or Indirect (I) (Instr. 5) 4. Nature of Indirect Beneficial Ownership (Instr. 5)
Ordinary Shares 959,752
D
Ordinary Shares 108,000
I
By spouse
Ordinary Shares 12,320,000
I
By trust
Table II - Derivative Securities Beneficially Owned
(e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 4) 2. Date Exercisable and Expiration Date (Month/Day/Year) 3. Title and Amount of Securities Underlying Derivative Security (Instr. 4) 4. Conversion or Exercise Price of Derivative Security 5. Ownership Form: Direct (D) or Indirect (I) (Instr. 5) 6. Nature of Indirect Beneficial Ownership (Instr. 5)
Date Exercisable Expiration Date Title Amount or Number of Shares
Restricted Shares Units (1) (1) Ordinary Shares (2) 960,000 (1) (2) D
Restricted Shares Units (3) (3) Ordinary Shares (4) 280,000 (3) (4) D
Option (right to buy) (5) 11/25/2033 Ordinary Shares (5) 16,000,000 (6) D
Option (right to buy) (7) 11/26/2035 Ordinary Shares (7) 12,000,000 (8) D
Option (right to buy) (9) 11/26/2035 Ordinary Shares (9) 12,000,000 (10) D
Explanation of Responses:
1. Reflects the outstanding unvested portion of a restricted share unit award granted in the form of American Depository Shares ("ADSs") that vests in five equal annual installments beginning on Sep 10, 2024, subject to the terms and conditions of the underlying award agreement.
2. Each restricted share unit represents a contingent right to receive one ADS. Each ADS represents 8 ordinary shares. This amount represents the ordinary shares underlying the ADSs in this award.
3. Reflects the outstanding unvested portion of a restricted share unit award granted in the form of ordinary shares that vests in twenty-four equal quarterly installments beginning on Jul 1, 2025, subject to the terms and conditions of the underlying award agreement.
4. Each restricted share unit represents a contingent right to receive one ordinary share.
5. Reflects an option award granted in the form of ADSs that vests in five equal annual installments beginning Sep 10, 2024, subject to the terms and conditions of the underlying award agreement. This amount represents the ordinary shares underlying the ADSs in this award.
6. The exercise price of this option US$78.37 per ADS.
7. Reflects an option award granted in the form of ordinary shares that vests in three equal annual installments beginning on Nov 26, 2026, subject to the terms and conditions of the underlying award agreement.
8. The exercise price of this option is HK$116.70 per share. The exercise price reported herein was converted from Hong Kong dollars to United States dollars at a conversion price of HK$116.70 to US$14.96.
9. Reflects an option award granted in the form of ordinary shares that vests in three equal annual installments beginning on Nov 26, 2029, subject to the terms and conditions of the underlying award agreement.
10. The exercise price of this option is HK$152.69 per share. The exercise price reported herein was converted from Hong Kong dollars to United States dollars at a conversion price of HK$152.69 to US$19.58.
/s/ Kevin Jinwei Zhang, as Attorney-in-Fact for Eddie Yongming Wu 03/18/2026
** Signature of Reporting Person Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.

ATTACHMENTS / EXHIBITS

EX-24

Categories

SEC Filings